WO2025141424 - -AMINOBENZOIC ACID COMPOUNDS IN THE PREPARATION OF MEDICAMENTS FOR TREATING COCCIDIOSIS IN ANIMALS
National phase entry is expected:
Publication Number
WO/2025/141424
Publication Date
03.07.2025
International Application No.
PCT/IB2024/062954
International Filing Date
20.12.2024
Title **
[English]
-AMINOBENZOIC ACID COMPOUNDS IN THE PREPARATION OF MEDICAMENTS FOR TREATING COCCIDIOSIS IN ANIMALS
[French]
-AMINOBENZOÏQUE DANS LA PRÉPARATION DE MÉDICAMENTS POUR LE TRAITEMENT DE LA COCCIDIOSE CHEZ LES ANIMAUX
Applicants **
ANIPHA TECHNOLOGIES PTY LTD
Inventors
PENG, Xianfeng
Priority Data
202311827975.7
28.12.2023
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
IP Australia
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2073 | |
| EPO | Filing, Examination, Granting | 11551 | |
| Japan | Filing, Examination, Granting | 2122 | |
| South Korea | Filing, Examination, Granting | 2066 | |
| USA | Filing, Examination, Granting | 4740 |

Total:
22,552
Contact Us
Abstract[English]
alkyl, the pharmaceutically acceptable salt is an alkali or divalent metal salt. The p-aminobenzoic acid compound or a pharmaceutically acceptable salt thereof as described herein, or a pharmaceutical composition comprising the same is remarkably effective against coccidiosis, and showed an obvious dose response.[French]
linéaire ou ramifié, le sel pharmaceutiquement acceptable est un sel de métal alcalin ou divalent. Le composé d'acide p-aminobenzoïque ou un sel pharmaceutiquement acceptable de celui-ci tel que décrit ici, ou une composition pharmaceutique le comprenant est remarquablement efficace contre la coccidiose, et a montré une réponse de dose évidente.